Blair Williams Todt - 01 Mar 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Reporting relationship: EVP, CLO & CAO
Issuer ticker: ELV
Reported as of: 01 Mar 2024
Net transaction value: -$1,821,752
SEC form: 4
Accepted by SEC: 05 Mar 2024, 16:29:57 UTC
Prior SEC filing: 05 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ Kathleen S. Kiefer, Attorney in fact

Key filing fact

Blair Williams Todt filed Form 4 for Elevance Health, Inc. (ELV) on 05 Mar 2024.

Key facts

This page summarizes Blair Williams Todt's Form 4 filing for Elevance Health, Inc. (ELV).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Mar 2024, 16:29.

Change

Previous filing in this sequence was filed on 05 Jan 2024.
Current net transaction value: -$1,821,752.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELV transaction

Common Stock

Tax liability

Transaction value: $1,821,752
Shares: -3,650
Change %: -30%
Price: $499.11
Shares after: 8,465
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F1

ELV transaction

Common Stock

Award

Transaction value: $0
Shares: +2,154
Change %: +25%
Price: $0.000000
Shares after: 10,619
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F2

ELV transaction

Common Stock

Award

Transaction value: $0
Shares: +6,537
Change %: +62%
Price: $0.000000
Shares after: 17,156
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELV transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +8,312
Change %
Price: $0.000000
Shares after: 8,312
Date: 01 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,312
Exercise price: $499.11
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Footnote F2

Represents restricted share units. Restrictions lapse as follows: 718 shares on 3/1/2025, 3/1/2026, and 3/1/2027.

Footnote F3

Represents performance based restricted share units. Restrictions lapse on 3/1/2024.

Footnote F4

The option represents a right to purchase a total of 8,312 shares, and is exercisable in one installment of 2,770 shares, and two installments of 2,771 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.